Trial NCT05093387

View at ClinicalTrials.gov 
Org. Study IDs: NU 19B07
Secondary IDs: NCI-2021-09317 NU 19B07 P30CA060553 STU00212682

Last trial update was posted on 2022-11-15

MeSH Interventions

Carboplatin Pembrolizumab

MeSH Conditions

Breast Neoplasms Carcinoma Inflammatory Breast Neoplasms

Other Conditions

Anatomic Stage IV Breast Cancer AJCC v8 Breast Inflammatory Carcinoma Metastatic Triple-Negative Breast Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Stopping Reasons

funding issues and pharmacy preparation for the drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID